AKRO PHARMACEUTICAL COMPANY LIMITED Financials
- Company number
- 03639498CopyCopy
- Registered office
- Abacus House, 68a North Street, Romford, Essex RM1 1DA
- Incorporated
- 28/09/1998
Company snapshot
- Status
- Active
- Employees
- 6 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
8.59%vs 20242024: £367.62K
Total Assets
9.97%vs 20242024: £1.83M
Cash in Bank
-15.23%vs 20242024: £172.17K
Total Liabilities
16.09%vs 20242024: £1.02M
Employees
+1vs 20242024: 5
In 2025, AKRO PHARMACEUTICAL COMPANY LIMITED reported net assets of £399.22K. The same filing shows total assets of £2.01M, cash in bank of £145.96K and total liabilities of £1.19M. Reported headcount was 6 in 2025. Total Assets rose from £1.83M in 2024 to £2.01M in 2025 (9.97%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
8.59%from £367.62K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures AKRO PHARMACEUTICAL COMPANY LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+20.7%vs 2023+9.9% a year compound (CAGR)
Cash in Bank
-57.2%vs 2023-34.6% a year compound (CAGR)
Employees
+20%vs 2023+1Biggest increase
Net Assets+20.7%
£330.74K in 2023 to £399.22K in 2025
Biggest decrease
Cash in Bank-57.2%
£341.05K in 2023 to £145.96K in 2025
AKRO PHARMACEUTICAL COMPANY LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.
Ratios from the filed figures
Calculated from AKRO PHARMACEUTICAL COMPANY LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 19.84%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 59.09%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 12.28%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 7.25%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for AKRO PHARMACEUTICAL COMPANY LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 269.22K | 282.69K | 330.74K | 367.62K | 399.22K |
| Total Assets£ | – | – | – | 1.83M | 2.01M |
| Cash in Bank£ | 273.91K | 290.58K | 341.05K | 172.17K | 145.96K |
| Total Liabilities£ | – | – | – | 1.02M | 1.19M |
| Employees | 5 | 5 | 5 | 5 | 6 |
AKRO PHARMACEUTICAL COMPANY LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for AKRO PHARMACEUTICAL COMPANY LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
AKRO PHARMACEUTICAL COMPANY LIMITED reported net assets of £399.22K for 2025. That compares with £367.62K in 2024, a change of 8.59%.
AKRO PHARMACEUTICAL COMPANY LIMITED reported total assets of £2.01M for 2025. That compares with £1.83M in 2024, a change of 9.97%.
AKRO PHARMACEUTICAL COMPANY LIMITED reported cash in bank of £145.96K for 2025. That compares with £172.17K in 2024, a change of -15.23%.
AKRO PHARMACEUTICAL COMPANY LIMITED reported 6 employees in 2025, compared with 5 in 2024.
Between 2023 and 2025, AKRO PHARMACEUTICAL COMPANY LIMITED's net assets rose by 20.7%, cash in bank fell by 57.2% and employee numbers rose by 20%. Net assets compounded at 9.9% a year across the two years to 2025, from £330.74K to £399.22K. Reported headcount went from 5 in 2023 to 6 in 2025 (+1).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.